The future of tendon and ligament healing
How BioBrace™ technology works
scroll
Introducing the BioBrace™ Implant
We pioneered the BioBrace™ implant to empower clinicians and raise the standard of care for the treatment of ligament and tendon injuries. The BioBrace™ implant is an innovative biocomposite scaffold that is intended for the reinforcement of soft tissue where weakness exists.The BioBrace is not yet FDA cleared for commercial sale or clinical use in the United States.
Breakthrough Biocomposite Scaffold
The proprietary biocomposite design of the BioBrace™ features a highly-porous collagen matrix, embedded with bioresorbable polymer microfilaments, to provide an open 3-D biologic scaffold with strength.
Reinforce
Its biomechanical profile enables load sharing to reinforce ligament and tendon repair throughout the healing process.
Regenerate
Through its proprietary open porous architecture and biocompatible materials, the BioBrace™ facilitates a rapid cellular infiltration to accelerate organized tissue regeneration.
Resorb
After the healing process is complete, the implant will fully resorb to restore the anatomy to its normal state.
In ACL reconstructive surgery tissue grafts are typically used to replace the ruptured ACL.
After the graft is implanted, the body repopulates new cells and blood vessels through the tissue graft to reconstitute a new ACL over time. Prolonged recovery following ACL reconstructive surgery remains a challenge for both the patient and surgeon. Biorez has designed and developed the BioBrace™ implant to help solve this problem.
Shortcomings of $7B sports medicine market.
The natural healing process for ligaments and tendons can be long and slow due to low cellular activity and low vascularity within connective tissues. As a result, rehabilitation and recovery are long, often incomplete, and risk of reinjury is high.
ACL
250,000 Surgeries
Up to 29% graft failure (1)
Rotator Cuff
460,000 Surgeries
Up to 34% re-tear (2)
Achilles
70,000 Surgeries
Up to 16% re-tear (3)
- (1) Barrett, AM et al. Anterior cruciate ligament graft failure: a comparison of graft type based on age and Tegner activity level. Am J Sports Med. 2011 Oct;39(10):2194-8.
- (2) Gerber C et al. The results of repair of massive tears of the rotator cuff. J Bone Joint Surg Am. 2000 Apr;82(4):505-15.
- (3) Rettig AC et al. Potential risk of rerupture in primary Achilles tendon repair in athletes younger than 30 years of age. Am J Sports Med. 2005 Jan;33(1):119-23.
The ability to optimize this healing process and shorten rehabilitation time would be a significant advancement.
